Newbury Pharmaceuticals 将来の成長
Future 基準チェック /66
Newbury Pharmaceuticals is forecast to grow earnings and revenue by 130% and 62.4% per annum respectively.
主要情報
130.0%
収益成長率
n/a
EPS成長率
| Pharmaceuticals 収益成長 | 69.5% |
| 収益成長率 | 62.4% |
| 将来の株主資本利益率 | 29.0% |
| アナリストカバレッジ | Low |
| 最終更新日 | 23 Oct 2024 |
今後の成長に関する最新情報
Recent updates
業績と収益の成長予測
| 日付 | 収益 | 収益 | フリー・キャッシュフロー | 営業活動によるキャッシュ | 平均アナリスト数 |
|---|---|---|---|---|---|
| 8/31/2026 | 141 | 17 | 9 | 15 | 1 |
| 8/31/2025 | 73 | 5 | 4 | 8 | 1 |
| 8/31/2024 | 37 | -15 | -27 | -24 | N/A |
| 5/31/2024 | 19 | -22 | -30 | -27 | N/A |
| 2/29/2024 | 23 | -17 | -29 | -26 | N/A |
| 11/30/2023 | 21 | -17 | -25 | -24 | N/A |
| 8/31/2023 | 10 | -19 | -24 | -23 | N/A |
| 5/31/2023 | 12 | -19 | -26 | -25 | N/A |
| 2/28/2023 | 7 | -18 | -26 | -21 | N/A |
| 11/30/2022 | 6 | -17 | -40 | -15 | N/A |
| 8/31/2022 | 6 | -15 | -39 | -15 | N/A |
| 5/31/2022 | 3 | -13 | -35 | -11 | N/A |
| 2/28/2022 | 3 | -12 | -35 | -15 | N/A |
| 11/30/2021 | 3 | -10 | -34 | -9 | N/A |
| 8/31/2021 | 3 | -6 | -30 | -4 | N/A |
アナリストによる今後の成長予測
収入対貯蓄率: NEWBRY is forecast to become profitable over the next 3 years, which is considered faster growth than the savings rate (1.1%).
収益対市場: NEWBRY is forecast to become profitable over the next 3 years, which is considered above average market growth.
高成長収益: NEWBRY is expected to become profitable in the next 3 years.
収益対市場: NEWBRY's revenue (62.4% per year) is forecast to grow faster than the Swedish market (0.01% per year).
高い収益成長: NEWBRY's revenue (62.4% per year) is forecast to grow faster than 20% per year.
一株当たり利益成長率予想
将来の株主資本利益率
将来のROE: NEWBRY's Return on Equity is forecast to be high in 3 years time (29%)